CME Objectives

Upon completion of this educational activity, participants should be able to:

  • describe new findings in the differential diagnosis and treatment of various diseases;
  • describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease;
  • identify cost-effective treatment regimens;
  • explain the advantages and disadvantages of new disease screening procedures.

CME Instructions

To earn credit for this activity, follow these instructions:

1. Read and study the activity, using the provided references for further research.

2. Log on to www.cmecity.com to take a post-test; tests can be taken after each issue or collectively at the end of the semester. First-time users will have to register on the site using the 8-digit subscriber number printed on their mailing label, invoice or renewal notice.

3. Pass the online tests with a score of 100%; you will be allowed to answer the questions as many times as needed to achieve a score of 100%.

4. After successfully completing the last test of the semester, your browser will be automatically directed to the activity evaluation form, which you will submit online.

5. Once the completed evaluation is received, a credit letter will be e-mailed to you instantly. You will no longer have to wait to receive your credit letter!

CME Questions

1. In the study by Eguale et al, the highest percentage of off-label prescriptions was for central nervous system medications. Which drug subgroup was prescribed off-label most commonly?

a. Anticonvulsants
b. Anti-anxiety medications
c. Antipsychotics
d. Antidepressants

2. Detection of aortic valve calcification on CT scanning:

a. is an interesting observation of little or minimal value.
b. is of significant value in predicting cardiovascular and coronary event risk in all patients.
c. is of clinical value only in patients with significantly abnormal traditional risk factors and/or abnormal inflammatory biomarkers.

3. All of the following are neuropsychiatric disorders associated with the use of glucocorticoids except:

a. mania.
b. depression.
c. suicide.
d. panic Disorder.
e. bipolar Disorder.